David Lillicrap Selected Research

David Lillicrap Research Topics

Disease

68	Hemophilia A (Haemophilia) 02/2024 - 04/2002
25	Hemorrhage 02/2024 - 03/2003
12	Thrombosis (Thrombus) 01/2023 - 06/2010
6	von Willebrand Diseases (von Willebrand's Disease) 03/2024 - 01/2007
5	Type 1 von Willebrand Disease 11/2023 - 07/2003
5	Thrombocytopenia (Thrombopenia) 04/2023 - 03/2003
5	COVID-19 12/2021 - 03/2021
4	Type 3 von Willebrand Disease 01/2022 - 01/2013
4	Hemophilia B (Haemophilia B) 12/2017 - 11/2005
3	Type 2 von Willebrand Disease 06/2010 - 08/2004
2	Inflammation (Inflammations) 01/2023 - 01/2022
2	Venous Thrombosis (Deep-Vein Thrombosis) 01/2023 - 12/2020
2	Pathologic Constriction (Stenosis) 01/2023 - 10/2021
2	Obesity 01/2022 - 12/2020
2	Venous Thromboembolism 10/2021 - 12/2020
2	Critical Illness (Critically Ill) 07/2021 - 01/2021
2	Wounds and Injuries (Trauma) 01/2021 - 01/2019
2	Disease Susceptibility (Diathesis) 01/2019 - 03/2003
1	Aromatic amino acid decarboxylase deficiency 10/2023
1	Retinal Diseases 10/2023
1	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 10/2023
1	Endotoxemia 01/2023
1	Seizures (Absence Seizure) 01/2022
1	Vomiting 01/2022
1	Headache (Headaches) 01/2022
1	Hypersensitivity (Allergy) 03/2021
1	Disseminated Intravascular Coagulation 01/2021
1	Sepsis (Septicemia) 01/2021
1	Dysbiosis 01/2020

Drug/Important Bio-Agent (IBA)

50	Factor VIII (Coagulation Factor VIII)IBA 02/2024 - 09/2002
23	von Willebrand FactorIBA 03/2024 - 07/2003
17	AntibodiesIBA 11/2023 - 12/2004
11	Proteins (Proteins, Gene)FDA Link 09/2023 - 09/2003
9	Hemostatics (Antihemorrhagics)IBA 02/2024 - 01/2006
6	Blood Coagulation Factors (Coagulation Factor)IBA 01/2023 - 09/2010
6	Factor IX (Coagulation Factor IX)FDA LinkGeneric 07/2021 - 03/2002
5	Neutralizing AntibodiesIBA 09/2023 - 12/2010
5	Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric 10/2022 - 01/2013
5	Immunoglobulin G (IgG)IBA 01/2020 - 05/2015
4	Heparin (Liquaemin)FDA LinkGeneric 12/2021 - 03/2021
4	fibrin fragment D (D-dimer)IBA 11/2021 - 03/2021
4	AntigensIBA 01/2021 - 11/2005
4	ferric chlorideIBA 01/2021 - 06/2010
3	CollagenIBA 09/2014 - 01/2013
3	CytokinesIBA 07/2009 - 03/2003
2	Monoclonal AntibodiesIBA 11/2023 - 01/2023
2	emicizumabIBA 11/2023 - 01/2020
2	VaccinesIBA 04/2023 - 11/2021
2	FibrinIBA 01/2023 - 04/2012
2	DNA (Deoxyribonucleic Acid)IBA 10/2021 - 12/2013
2	AnticoagulantsIBA 07/2021 - 03/2021
2	Thrombin FDA Link 01/2021 - 11/2005
2	Antigen-Antibody Complex (Immune Complex)IBA 11/2018 - 06/2014
2	Thromboplastin (Tissue Factor)IBA 07/2018 - 04/2012
2	IsoantibodiesIBA 02/2015 - 08/2013
2	NucleotidesIBA 08/2009 - 11/2004
2	Interleukin-6 (Interleukin 6)IBA 07/2009 - 03/2003
1	PlasminogenIBA 02/2024
1	Small Interfering RNA (siRNA)IBA 02/2024
1	Lipid NanoparticlesIBA 02/2024
1	Antifibrinolytic Agents (Antifibrinolytics)IBA 02/2024
1	Tranexamic Acid (AMCA)FDA Link 02/2024
1	Fibrinolysin FDA Link 02/2024
1	Bispecific AntibodiesIBA 02/2024
1	LipopolysaccharidesIBA 01/2023
1	Cysteine (L-Cysteine)FDA Link 10/2022
1	Valoctocogene RoxaparvovecIBA 09/2022
1	AutoantibodiesIBA 01/2022
1	Ad26COVS1IBA 11/2021
1	ChAdOx1 nCoV-19IBA 11/2021
1	apixabanIBA 03/2021
1	edoxabanIBA 03/2021
1	RivaroxabanIBA 03/2021
1	Dabigatran FDA Link 03/2021
1	Fibrinogen (Factor I)FDA Link 03/2021
1	Hemoglobins (Hemoglobin)IBA 03/2021
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 03/2021
1	Nucleic AcidsIBA 03/2021
1	Prothrombin (Factor II)IBA 03/2021
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 03/2021
1	Warfarin (Coumadin)FDA LinkGeneric 03/2021
1	Biomarkers (Surrogate Marker)IBA 03/2021
1	Fibrillar CollagensIBA 01/2021
1	ABO Blood-Group SystemIBA 01/2021
1	Histones (Histone)IBA 01/2021
1	Dacarbazine (DIC)FDA LinkGeneric 01/2021
1	multimerinIBA 01/2021
1	3' Untranslated Regions (3' UTR)IBA 11/2020
1	Hypochlorous Acid (Hypochlorite)IBA 01/2020
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020
1	Poly TIBA 01/2020
1	ADAMTS13 ProteinIBA 04/2019
1	CoagulantsIBA 01/2019

Therapy/Procedure

28	Therapeutics 10/2023 - 07/2006
2	Artificial Respiration (Mechanical Ventilation) 10/2021 - 03/2021
1	Ambulatory Care (Outpatient Care) 10/2021
1	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 03/2021
1	Renal Replacement Therapy (Therapies, Renal Replacement) 03/2021
1	Erythrocyte Transfusion 03/2021